On the subject in the title: Second pass at: Robustness: the parameters worth deliberately varying Working notes rather than a conclusion.
I would like to understand what this number means before I repeat it anywhere.
A VendorInvestigate report on a semaglutide lot gives 97.8% purity. The supplier certificate for the same lot states 98%. Both documents name a reversed-phase method; neither states the same gradient.
My question is not "who is right". It is: given that those two figures were produced by different methods, what is the largest difference I should expect from method alone, and at what point does a gap stop being explainable that way?